BACKGROUNDIn the Alzheimer’s brain, hard plaques accumulate between the nerve cells while twisted fibers grow inside the nerve cells. The plaques arise from protein fragments called beta amlyoid, and the fibers form from a protein called tau. Doctors rely on brain scans to detect amyloid and tau and provide early intervention and treatment to potentially slow or reverse disease progression.

FINDINGSHow the imaging agents work that scan the Alzheimer’s brain is unknown. A new UCLA study reveals the physical mechanisms that allow chemical agents to bind to and detect amyloid beta plaques and tau tangles in the brain. The discovery will speed the development of new imaging agents, enabling quicker diagnosis and earlier treatment.

AUTHORSKendall Houk, Saul Winstein Professor of Organic Chemistry at UCLA’s College of Letters and Sciences; and Jorge Barrio, distinguished professor of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, are available for interviews.

JOURNALThe Proceedings of the National Academy of Sciences publishes the findings online during the week of Sept. 24 in its early edition.

FUNDINGThe study was supported by funding from the National Institute of General Medical Sciences.

GRAPHICSColor illustrations of imaging agents available upon request.

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

Proceedings of the National Academy of Sciences